Smith Cathy R

SEC source: 0001225208-26-005112 · doc4.xml · derivative · entry 2

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,888

Underlying: Common Stock · 2,209 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F4 · shares: Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant.

F4 · derivative.exercise_date: Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant.

F4 · derivative.expiration_date: Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant.

SEC source: 0001225208-26-005112 · doc4.xml · derivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,679

Underlying: Common Stock · 3,800 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2 · shares: Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.

F3 · derivative.exercise_date: Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

F3 · derivative.expiration_date: Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

SEC source: 0000079879-26-000146 · wk-form4_1776447684.xml · derivative · entry 4

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,684

Underlying: Common Stock · 1,684 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PPG common stock.

F3 · derivative.exercise_date: The restricted stock units vest on April 14, 2027.

F3 · derivative.expiration_date: The restricted stock units vest on April 14, 2027.

SEC source: 0000079879-26-000146 · wk-form4_1776447684.xml · derivative · entry 3

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,849 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon the vesting of restricted stock units on April 15, 2026, which were granted to the reporting person on April 17, 2025, the reporting person is reporting the acquisition of 1,849 shares of common stock.

F1 · derivative.exercise_date: Upon the vesting of restricted stock units on April 15, 2026, which were granted to the reporting person on April 17, 2025, the reporting person is reporting the acquisition of 1,849 shares of common stock.

F1 · derivative.expiration_date: Upon the vesting of restricted stock units on April 15, 2026, which were granted to the reporting person on April 17, 2025, the reporting person is reporting the acquisition of 1,849 shares of common stock.

SEC source: 0000079879-26-000146 · wk-form4_1776447684.xml · nonDerivative · entry 2

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,495

SEC source: 0000079879-26-000146 · wk-form4_1776447684.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the vesting of restricted stock units on April 15, 2026, which were granted to the reporting person on April 17, 2025, the reporting person is reporting the acquisition of 1,849 shares of common stock.

SEC source: 0000829224-26-000029 · form4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · evp, cfo

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,751.726

F1 · shares: Shares withheld by the issuer to satisfy tax withholding obligations upon vesting of restricted stock units; not an open market transaction.

F2 · balance_after: Includes 860.423 shares representing dividend equivalents on unvested time-based restricted stock units.

SEC source: 0001225208-26-003177 · doc4.xml · derivative · entry 2

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 879

Underlying: Common Stock · 323 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F3 · derivative.exercise_date: Grant of deferred stock units in lieu of 100% yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2026 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $24,662.50 (representing 100% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

F3 · derivative.expiration_date: Grant of deferred stock units in lieu of 100% yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2026 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $24,662.50 (representing 100% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

SEC source: 0001225208-26-003177 · doc4.xml · derivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 556

Underlying: Common Stock · 556 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2 · derivative.exercise_date: Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2026 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $42,419.50 (representing 100% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

F3 · derivative.expiration_date: Grant of deferred stock units in lieu of 100% yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2026 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $24,662.50 (representing 100% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

SEC source: 0000829224-25-000127 · form4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · evp, cfo

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,122.738

F1 · shares: Shares withheld by the issuer to satisfy tax withholding obligations upon vesting of restricted stock units; not an open market transaction.

SEC source: 0000829224-25-000095 · form4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · evp, cfo

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,027

F1 · shares: Restricted stock units granted on November 11, 2025 and vests in one increment of 5,208 shares on November 11, 2026, and three increments of 5,207 shares each on November 11, 2027, November 11, 2028, and November 11, 2029.

F2 · balance_after: Includes 648 shares representing dividend equivalents on unvested time-based RSUs.

SEC source: 0001062993-25-008903 · form4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,345

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0000079879-25-000120 · wk-form4_1745001076.xml · derivative · entry 4

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,849

Underlying: Common Stock · 1,849 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PPG common stock.

F3 · derivative.exercise_date: The restricted stock units vest on April 15, 2026.

F3 · derivative.expiration_date: The restricted stock units vest on April 15, 2026.

SEC source: 0000079879-25-000120 · wk-form4_1745001076.xml · derivative · entry 3

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,368 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon the vesting of restricted stock units on April 16, 2025, which were granted to the reporting person on April 18, 2024, the reporting person is reporting the acquisition of 1,368 shares of common stock.

F1 · derivative.exercise_date: Upon the vesting of restricted stock units on April 16, 2025, which were granted to the reporting person on April 18, 2024, the reporting person is reporting the acquisition of 1,368 shares of common stock.

F1 · derivative.expiration_date: Upon the vesting of restricted stock units on April 16, 2025, which were granted to the reporting person on April 18, 2024, the reporting person is reporting the acquisition of 1,368 shares of common stock.

SEC source: 0000079879-25-000120 · wk-form4_1745001076.xml · nonDerivative · entry 2

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,652

SEC source: 0000079879-25-000120 · wk-form4_1745001076.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,657

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the vesting of restricted stock units on April 16, 2025, which were granted to the reporting person on April 18, 2024, the reporting person is reporting the acquisition of 1,368 shares of common stock.

SEC source: 0001127602-25-010502 · form4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · evp, cfo

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,550

F1 · shares: Represents two grants of restricted stock units granted on March 24, 2025. One grant in the amount of 26,745 shares vests in three increments of 8,915 shares each on March 24, 2026, March 24, 2027 and March 24, 2028; and the other grant of 18,805 shares vests one increment of 4,702 shares on November 19, 2025, and three increments of 4,701 shares each on November 19, 2026, November 19, 2027 and November 19, 2028.

SEC source: 0000072333-25-000031 · wk-form4_1741813025.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 433,655

F1 · shares: Represents shares withheld to satisfy the tax obligation in connection with the vesting of RSUs. The transaction is exempt pursuant to Rule 16b-3(e) of the 1934 Act.

SEC source: 0000072333-24-000128 · wk-form4_1733522847.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438,963

F1 · shares: Represents shares withheld to satisfy the tax obligation in connection with the vesting of RSUs. The transaction is exempt pursuant to Rule 16b-3(e) of the '34 Act.

SEC source: 0000072333-24-000085 · wk-form4_1718127441.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 441,722

F1 · shares: Represents shares withheld to satisfy the tax obligation in connection with the vesting of RSUs. The transaction is exempt pursuant to Rule 16b-3(e) of the '34 Act.

SEC source: 0001062993-24-009786 · form4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,545

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0000079879-24-000106 · wk-form4_1713545323.xml · derivative · entry 4

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,368

Underlying: Common Stock · 1,368 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PPG common stock.

F3 · derivative.exercise_date: The restricted stock units vest on April 16, 2025.

F3 · derivative.expiration_date: The restricted stock units vest on April 16, 2025.

SEC source: 0000079879-24-000106 · wk-form4_1713545323.xml · derivative · entry 3

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,174 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon the vesting of restricted stock units on April 17, 2024, which were granted to the reporting person on April 20, 2023, the reporting person is reporting the acquisition of 1,174 shares of common stock.

F1 · derivative.exercise_date: Upon the vesting of restricted stock units on April 17, 2024, which were granted to the reporting person on April 20, 2023, the reporting person is reporting the acquisition of 1,174 shares of common stock.

F1 · derivative.expiration_date: Upon the vesting of restricted stock units on April 17, 2024, which were granted to the reporting person on April 20, 2023, the reporting person is reporting the acquisition of 1,174 shares of common stock.

SEC source: 0000079879-24-000106 · wk-form4_1713545323.xml · nonDerivative · entry 2

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,289

SEC source: 0000079879-24-000106 · wk-form4_1713545323.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,292

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the vesting of restricted stock units on April 17, 2024, which were granted to the reporting person on April 20, 2023, the reporting person is reporting the acquisition of 1,174 shares of common stock.

SEC source: 0000072333-24-000024 · wk-form4_1710190051.xml · derivative · entry 2

Smith Cathy R · CIK 0001322028 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,912

Underlying: Common Stock · 79,912 shares

Expires 2027-03-10

F2 · derivative.exercise_price: Each Performance Share Unit (PSU) represents a contingent right to receive 1 share of the Company's common stock. The PSUs may be earned over a 3-year period from FY 2024 through FY 2026, depending on the achievement of certain metrics. The number of PSUs to be awarded is a function of established long-term incentive award levels, a PSU LTI% and the fair value of a PSU. The fair value of a PSU is calculated as the stock price as of the effective date less the present value of Company stock dividends over the vesting period. This calculation requires the input of certain assumptions, including the risk-free interest rate and the expected Company stock dividends. The formula for determining the number of PSUs granted is: number of PSUs = (base pay x PSU LTI%) / PSU fair value. The percentage of PSUs that will actually be earned at the end of each year within the 3-year period is based upon the Company's sales and earnings before interest and tax (EBIT) margin results over that year.

F3 · derivative.exercise_price: One third of the total target number of PSUs will be allocated to three separate 1-year performance cycles. The minimum percentage of PSUs that can be earned at the end of each year is 0% and the maximum is 175% based on achievement against Company sales and earnings before interest and tax (EBIT) margin results at the end of each year. The total percentage of PSUs that can be earned at the end of the 3-year period ranges from 0%-175%.

SEC source: 0000072333-24-000024 · wk-form4_1710190051.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 495,668

F1 · shares: Restricted Stock Unit vesting in three equal annual installments commencing on March 10, 2025. The number of RSUs awarded is a function of established long-term incentive award levels, an RSU long-term incentive (LTI) percentage, and the fair value of an RSU. The fair value of an RSU is calculated as the stock price as of the effective date less the present value of Company stock dividends over the vesting period. This calculation requires the input of certain assumptions, including the risk-free interest rate and the expected Company stock dividends. The formula for determining the number of RSUs granted is: number of RSUs = (base pay x RSU LTI%) / RSU fair value.

SEC source: 0000072333-23-000099 · wk-form4_1686076567.xml · nonDerivative · entry 2

Smith Cathy R · CIK 0001322028 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 422,391

F2 · shares: Restricted Stock Units vesting in two equal installments on June 10, 2025 and June 10, 2026. The number of RSUs awarded is a function of target award value and the fair value of an RSU. The fair value of an RSU is calculated as the stock price as of the effective date less the present value of Company stock dividends over the vesting period. This calculation requires the input of certain assumptions, including the risk-free interest rate and the expected Company stock dividends. The formula for determining the number of RSUs granted is: number of RSUs = target award value / RSU fair value.

SEC source: 0000072333-23-000099 · wk-form4_1686076567.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,024

F1 · shares: Restricted Stock Unit vesting 55% on June 10, 2024, 25% on June 10, 2025 and 20% on June 10, 2026. The number of RSUs awarded is a function of target award value and the fair value of an RSU. The fair value of an RSU is calculated as the stock price as of the effective date less the present value of Company stock dividends over the vesting period. This calculation requires the input of certain assumptions, including the risk-free interest rate and the expected Company stock dividends. The formula for determining the number of RSUs granted is: number of RSUs = target award value / RSU fair value.

SEC source: 0001062993-23-010214 · form4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,130

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001209191-23-025088 · doc4.xml · derivative · entry 3

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,174

Underlying: Common Stock · 1,174 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PPG Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest on April 17, 2024.

F3 · derivative.expiration_date: The restricted stock units vest on April 17, 2024.

SEC source: 0001209191-23-025088 · doc4.xml · derivative · entry 2

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,232 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon the vesting of restricted stock units on April 19, 2023, which were granted to the reporting person on April 21, 2022, the reporting person is reporting the acquisition of 1,232 shares of common stock.

F1 · derivative.exercise_date: Upon the vesting of restricted stock units on April 19, 2023, which were granted to the reporting person on April 21, 2022, the reporting person is reporting the acquisition of 1,232 shares of common stock.

F1 · derivative.expiration_date: Upon the vesting of restricted stock units on April 19, 2023, which were granted to the reporting person on April 21, 2022, the reporting person is reporting the acquisition of 1,232 shares of common stock.

SEC source: 0001209191-23-025088 · doc4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the vesting of restricted stock units on April 19, 2023, which were granted to the reporting person on April 21, 2022, the reporting person is reporting the acquisition of 1,232 shares of common stock.

SEC source: 0001628280-23-008171 · wf-form4_167892806772781.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · CFO & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,157

F1 · shares: These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.38 to $0.41 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001628280-23-007411 · wf-form4_167841183736978.xml · derivative · entry 2

Smith Cathy R · CIK 0001322028 · CFO & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 521,416

Underlying: Common Stock · 260,707 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on March 7, 2023.

F2 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on March 7, 2023.

SEC source: 0001628280-23-007411 · wf-form4_167841183736978.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · CFO & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 403,330

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001628280-23-000528 · wf-form4_167296045541020.xml · derivative · entry 1

Smith Cathy R · CIK 0001322028 · CFO & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,806,312

Underlying: Common Stock · 2,806,312 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: All restricted stock units vest on the second anniversary of the grant date.

F2 · derivative.expiration_date: All restricted stock units vest on the second anniversary of the grant date.

SEC source: 0001062993-22-011691 · form4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,299

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001209191-22-025294 · doc4.xml · derivative · entry 3

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,232

Underlying: Common Stock · 1,232 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PPG Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest on April 19, 2023.

F3 · derivative.expiration_date: The restricted stock units vest on April 19, 2023.

SEC source: 0001209191-22-025294 · doc4.xml · derivative · entry 2

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 947 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon the vesting of restricted stock units on April 20, 2022, which were granted to the reporting person on April 15, 2021, the reporting person is reporting the acquisition of 947 shares of common stock.

F1 · derivative.exercise_date: Upon the vesting of restricted stock units on April 20, 2022, which were granted to the reporting person on April 15, 2021, the reporting person is reporting the acquisition of 947 shares of common stock.

F1 · derivative.expiration_date: Upon the vesting of restricted stock units on April 20, 2022, which were granted to the reporting person on April 15, 2021, the reporting person is reporting the acquisition of 947 shares of common stock.

SEC source: 0001209191-22-025294 · doc4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,886

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the vesting of restricted stock units on April 20, 2022, which were granted to the reporting person on April 15, 2021, the reporting person is reporting the acquisition of 947 shares of common stock.

SEC source: 0001415889-22-002810 · form4-03092022_030327.xml · derivative · entry 2

Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,489,758

Underlying: Common Stock · 1,489,758 shares

Expires 2032-03-07

F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on March 7, 2023.

SEC source: 0001415889-22-002810 · form4-03092022_030327.xml · derivative · entry 1

Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 782,123

Underlying: Common Stock · 782,123 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on March 7, 2023.

F2 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on March 7, 2023.

SEC source: 0001415889-21-006044 · form4-12162021_041207.xml · derivative · entry 1

Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,700,000

Underlying: Common Stock · 1,700,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of BHG common stock.

F2 · derivative.exercise_date: The restricted stock units vest 60% on the 2nd anniversary of the grant date and 40% on the 3rd anniversary of the grant date.

F2 · derivative.expiration_date: The restricted stock units vest 60% on the 2nd anniversary of the grant date and 40% on the 3rd anniversary of the grant date.

SEC source: 0001415889-21-003299 · form4-06302021_090602.xml · derivative · entry 16

Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,050,000

Underlying: Common Stock · 1,050,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").

F3 · derivative.exercise_date: These performance-based restricted stock units ("PSUs") shall vest if the performance conditions described below are met.

F4 · derivative.exercise_date: These PSUs shall vest as follows if the following price per share goals are met.

F3 · derivative.expiration_date: These performance-based restricted stock units ("PSUs") shall vest if the performance conditions described below are met.

F4 · derivative.expiration_date: These PSUs shall vest as follows if the following price per share goals are met.

SEC source: 0001415889-21-003299 · form4-06302021_090602.xml · derivative · entry 26

Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,694,877

Underlying: Common Stock · 5,124 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: These stock options vest over four years as follows: (a) 25% vested on January 6, 2021, and (b) 1/48 of the original grant amount (2,550,000) vests in monthly installments for the following three years.

SEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 15

Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,623

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-21-003299 · form4-06302021_090602.xml · derivative · entry 25

Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 412,500

Underlying: Common Stock · 12,501 shares

Expires 2030-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: These stock options vest over four years as follows: (a) 25% vested on February 19, 2021, and (b) 1/48 of the original grant amount (600,000) vests in monthly installments for the following three years.

SEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 14

Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,499

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-21-003299 · form4-06302021_090602.xml · derivative · entry 24

Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,700,001

Underlying: Common Stock · 53,124 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: These stock options vest over four years as follows: (a) 25% vested on January 6, 2021, and (b) 1/48 of the original grant amount (2,550,000) vests in monthly installments for the following three years.